Identification of MHC Class II-restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, That Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice
Overview
Affiliations
Nonobese diabetic (NOD) mice spontaneously develop insulitis and destruction of pancreatic islet beta cells similar to type 1 diabetes mellitis in humans. Insulitis also occurs in the BDC2.5 TCR transgenic line of NOD mice that express the rearranged TCR alpha- and beta-chain genes of a diabetogenic NOD CD4 T cell clone. When activated with syngeneic islet cells in culture, BDC2.5 T cells adoptively transfer disease to NOD recipients, but the identity of the islet cell Ag responsible for pathogenicity is not known. To characterize the autoantigen(s) involved, BDC2.5 T cells were used to screen a combinatorial peptide library arranged in a positional scanning format. We identified more than 100 decapeptides that stimulate these T cells at nanomolar concentrations; they are then capable of transferring disease to NOD-scid mice. Surprisingly, some of the peptides include sequences similar (8 of 10 residues) to those found within the 528-539 fragment of glutamic acid decarboxylase 65. Although this 12-mer glutamic acid decarboxylase 65 fragment is only slightly stimulatory for BDC2.5 T cells (EC(50) > 100 microM), a larger 16-mer fragment, 526-541, shows activity in the low micromolar range (EC(50) = 2.3 microM). Finally, T cells from prediabetic NOD mice respond spontaneously to these peptide analogs in culture; this finding validates them as being related to a critical autoantigen involved in the etiology of spontaneous diabetes and indicates that their further characterization is important for a better understanding of underlying disease mechanisms.
Insulin-degrading enzyme regulates insulin-directed cellular autoimmunity in murine type 1 diabetes.
Bessard M, Moser A, Waeckel-Enee E, Lindo V, Gdoura A, You S Front Immunol. 2024; 15:1474453.
PMID: 39600694 PMC: 11588737. DOI: 10.3389/fimmu.2024.1474453.
Antigen-specific T cell responses in autoimmune diabetes.
Dwyer A, Shaheen Z, Fife B Front Immunol. 2024; 15:1440045.
PMID: 39211046 PMC: 11358097. DOI: 10.3389/fimmu.2024.1440045.
De novo identification of CD4 T cell epitopes.
Zdinak P, Trivedi N, Grebinoski S, Torrey J, Martinez E, Martinez S Nat Methods. 2024; 21(5):846-856.
PMID: 38658646 PMC: 11093748. DOI: 10.1038/s41592-024-02255-0.
Pearson J, Hu Y, Peng J, Wong F, Wen L Front Immunol. 2024; 15:1333967.
PMID: 38482010 PMC: 10935730. DOI: 10.3389/fimmu.2024.1333967.
NLRP6 deficiency expands a novel CD103 B cell population that confers immune tolerance in NOD mice.
Pearson J, Peng J, Huang J, Yu X, Tai N, Hu Y Front Immunol. 2023; 14:1147925.
PMID: 36911699 PMC: 9995752. DOI: 10.3389/fimmu.2023.1147925.